Oncologie
Intensieve behandeling met transfusiealternatieven
Acute leukaemia in Jehovah's Witnesses. (opent nieuw venster)
Bron: Haematologica 2001;86(2):E02.
Geïndexeerd: PubMed 11224505
https://www.ncbi.nlm.nih.gov/pubmed/11224505 (opent nieuw venster)
Leczenie ostrej białaczki u Świadków Jehowy—opis przypadku i przegląd piśmiennictwa. [Treatment of acute leukemia in Jehovah's Witnesses—a case report and review of the literature.] [Polish, English abstract] (opent nieuw venster)
Bron: Acta Haematol Pol 2007;38(4):479-84.
Geïndexeerd: EMBASE 2008089811
Treatment of acute leukaemia in adult Jehovah's Witnesses. (opent nieuw venster)
Bron: Br J Haematol 2020;190(5):696-707.
Geïndexeerd: PubMed 31693175
DOI: 10.1111/bjh.16284
https://www.ncbi.nlm.nih.gov/pubmed/31693175 (opent nieuw venster)
Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (opent nieuw venster)
Bron: J Clin Oncol 2015;33(15):1674-9.
Geïndexeerd: PubMed 25870085
DOI: 10.1200/JCO.2014.57.9912
https://www.ncbi.nlm.nih.gov/pubmed/25870085 (opent nieuw venster)
Should Jehovah's Witnesses be denied intensive chemotherapy for acute leukemia? (opent nieuw venster)
Bron: N Engl J Med 1990;322(11):777-8.
Geïndexeerd: PubMed 2308609
DOI: 10.1056/NEJM199003153221115
https://www.ncbi.nlm.nih.gov/pubmed/2308609 (opent nieuw venster)
Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (opent nieuw venster)
Bron: Bone Marrow Transplant 2003;32(4):433-6.
Geïndexeerd: PubMed 12900781
DOI: 10.1038/sj.bmt.1704179
https://www.ncbi.nlm.nih.gov/pubmed/12900781 (opent nieuw venster)
Developing a blood conservation care plan for Jehovah's Witness patients with malignant disease. (opent nieuw venster)
Bron: Presented at the British Society for Haematology 47th Annual Scientific Meeting, Bournemouth [UK] April 2007.
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (opent nieuw venster)
Bron: Leuk Lymphoma. 2019;60(9):2324-7.
Geïndexeerd: PubMed 30773115
DOI: 10.1080/10428194.2019.1577414
https://www.ncbi.nlm.nih.gov/pubmed/30773115 (opent nieuw venster)
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses. (opent nieuw venster)
Bron: Leuk Lymphoma 2021;62(6):1497-501.
Geïndexeerd: PubMed 33535838
DOI: 10.1080/10428194.2021.1876868
https://www.ncbi.nlm.nih.gov/pubmed/33535838 (opent nieuw venster)